AesMed Successfully Exhibits at Cosmoprof Asia 2025 and Announces Full-Scale Global Expansion Strategy for 2026

AesMed Successfully Exhibits at Cosmoprof Asia 2025 and Announces Full-Scale Global Expansion Strategy for 2026
AesMed is pleased to announce the successful completion of its exhibition at Cosmoprof Asia 2025, held from November 12–14 at the Hong Kong Convention & Exhibition Centre (HKCEC).
 

As one of the world’s premier beauty and personal care exhibitions, Cosmoprof Asia provided an important platform for AesMed to present its advanced hair-loss treatment technologies and to strengthen connections with international buyers and industry leaders.
During the three-day event, AesMed showcased a range of its signature innovations, including:
•    AGF39™ Cytokines Therapy, a next-generation mesotherapy solution for hair-cycle normalization and follicle regeneration
•    4th Generation Advance Follicle Shampoo, formulated with nonionic surfactants and available in two scalp-specific versions for Dry & Dandruff and Seborrheic scalp types
•    Key awareness and education initiatives such as the 1111 Hair Care Day Campaign, AesMed’s international non-profit program for alopecia support and global collaboration
 

Visitors from various regions expressed strong interest in AesMed’s cytokine-based solutions, with many exploring partnership opportunities for clinical integration, distribution, and future cooperative projects.

AesMed to Begin Full-Scale Global Expansion in 2026
Following the positive reception at Cosmoprof Asia 2025, AesMed announced that it will begin implementing a full-scale global business strategy in 2026.
Key components of this expansion plan include:
•    Strengthening distributor networks across Asia, Europe, and the Middle East
•    Launching AGF39™ and the Advance Follicle Shampoo line in priority international markets
•    Expanding clinical collaboration programs with hair-loss hospitals worldwide
•    Enhancing digital marketing and e-commerce networks to improve global accessibility
•    Developing localized professional training programs for cytokine-based alopecia care
 

AesMed aims to establish itself as a global leader in cytokine-driven hair restoration science, delivering scientifically validated, patient-centered solutions to both clinics and end-users worldwide.
 

An AesMed representative stated:
“Our successful participation at Cosmoprof Asia 2025 marks an important turning point for AesMed. Beginning in 2026, we will accelerate our global expansion to bring our cytokine therapy and scalp care innovations to major markets around the world.”

AesMed’s Commitment to Global Innovation
AesMed extends its appreciation to all international partners, medical professionals, and industry delegates who visited the booth during Cosmoprof Asia 2025.
The company will continue to engage in global exhibitions, research collaborations, and professional partnerships as part of its mission to improve the quality of life for people affected by hair loss.